Carmell (CTCX) Competitors $0.22 0.00 (-0.77%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CTCX vs. NRXS, MBOT, NEPH, LUCY, LFWD, IINN, SSKN, MHUA, LYRA, and PYPDShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include NeurAxis (NRXS), Microbot Medical (MBOT), Nephros (NEPH), Innovative Eyewear (LUCY), ReWalk Robotics (LFWD), Inspira Technologies Oxy B.H.N. (IINN), STRATA Skin Sciences (SSKN), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. Carmell vs. NeurAxis Microbot Medical Nephros Innovative Eyewear ReWalk Robotics Inspira Technologies Oxy B.H.N. STRATA Skin Sciences Meihua International Medical Technologies Lyra Therapeutics PolyPid NeurAxis (NASDAQ:NRXS) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, community ranking, risk and institutional ownership. Do insiders & institutionals have more ownership in NRXS or CTCX? 11.8% of NeurAxis shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 15.2% of NeurAxis shares are held by insiders. Comparatively, 29.0% of Carmell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, NRXS or CTCX? NeurAxis has a beta of 4.15, indicating that its share price is 315% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Does the MarketBeat Community prefer NRXS or CTCX? NeurAxis received 1 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformNeurAxisOutperform Votes1100.00% Underperform VotesNo VotesCarmellN/AN/A Does the media prefer NRXS or CTCX? In the previous week, Carmell had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Carmell and 0 mentions for NeurAxis. Carmell's average media sentiment score of 0.67 beat NeurAxis' score of 0.00 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment NeurAxis Neutral Carmell Positive Is NRXS or CTCX more profitable? Carmell has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets NeurAxis-492.76% N/A -641.25% Carmell N/A -217.50%-50.22% Which has higher earnings & valuation, NRXS or CTCX? NeurAxis has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeurAxis$2.46M6.82-$14.63M-$1.84-1.30Carmell$32.84K140.30-$15.44MN/AN/A SummaryCarmell beats NeurAxis on 7 of the 12 factors compared between the two stocks. Ad MyBankTrackerYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.View the best savings account rates here Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.64M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E RatioN/A25.0189.7417.16Price / Sales140.3045.901,117.09117.04Price / CashN/A43.4443.1037.86Price / Book0.217.094.784.78Net Income-$15.44M$13.64M$120.31M$225.60M7 Day Performance4.95%-2.93%-1.92%-1.23%1 Month Performance-10.22%-1.42%13.65%0.46%1 Year Performance-94.71%39.20%28.34%15.24% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmell1.2693 of 5 stars$0.22-0.8%N/A-94.5%$4.64M$32,839.000.0014News CoveragePositive NewsNRXSNeurAxisN/A$2.51+1.2%N/A+5.3%$17.52M$2.46M-1.3519Gap DownHigh Trading VolumeMBOTMicrobot Medical1.9092 of 5 stars$1.00flat$7.00+600.0%-29.2%$16.93MN/A-1.2520NEPHNephros1.6901 of 5 stars$1.55flat$5.00+222.6%-47.6%$16.34M$13.55M-17.2230Positive NewsLUCYInnovative Eyewear1.7076 of 5 stars$6.52+6.7%$20.00+206.7%-32.6%$15.92M$1.56M-0.669LFWDReWalk Robotics3.3589 of 5 stars$1.63-1.2%$13.00+697.5%N/A$14.36M$25.00M-0.6260Positive NewsHigh Trading VolumeIINNInspira Technologies Oxy B.H.N.0.3107 of 5 stars$1.12-4.3%N/A-21.9%$14.14MN/A0.0020SSKNSTRATA Skin Sciences1.0225 of 5 stars$2.99-0.3%N/A-51.5%$12.47M$32.68M-1.11120Positive NewsMHUAMeihua International Medical Technologies0.6856 of 5 stars$0.49-1.5%N/A-86.4%$12.38M$94.25M0.00620Gap DownLYRALyra Therapeutics2.4053 of 5 stars$0.19+1.6%$4.50+2,324.6%-96.1%$12.15M$1.47M-0.1250Gap DownPYPDPolyPid2.3304 of 5 stars$2.43-6.9%$12.00+393.8%-17.6%$11.66MN/A-0.3080Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies NRXS Alternatives MBOT Alternatives NEPH Alternatives LUCY Alternatives LFWD Alternatives IINN Alternatives SSKN Alternatives MHUA Alternatives LYRA Alternatives PYPD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CTCX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.